Yoav Shaked Files Form 4: 20,000 Restricted Shares, Vesting Over Two Years

Rhea-AI Filing Summary

DarioHealth Corp. (DRIO) director Yoav Shaked reported a restricted share award granted and recorded on 09/11/2025. The filing shows an acquisition of 20,000 shares of common stock at a reported price of $0, structured to vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period. After accounting for a 20-for-1 reverse stock split effected on August 28, 2025, the number of shares beneficially owned by Mr. Shaked is shown as 32,810.

The report also discloses indirect ownership of 84 shares held by the reporting person’s spouse, with the reporting person disclaiming beneficial ownership of those shares. The form is signed by Yoav Shaked on 09/15/2025.

Positive

• Restricted share award disclosed (20,000 shares), signaling director alignment with shareholders through equity compensation
• Clear vesting schedule specified: two equal installments on successive annual anniversaries, which supports retention incentives
• Proper disclosure of reverse split impact with adjusted beneficial ownership shown (32,810 after 20-for-1 split)
• Spousal holdings disclosed and disclaimer provided, demonstrating compliance with Section 16 reporting rules

Negative

• None.

Insights

Securities Analyst

TL;DR: Director received a restricted share award (20,000 shares pre-split) that vests over two years; filings reflect reverse split adjustment.

The filing documents a non-cash compensation event: a restricted share award acquired on 09/11/2025 for 20,000 shares at a $0 price, indicating an equity grant rather than a market purchase. Vesting occurs in two equal annual installments, which spreads recognition and retention incentives over two years. The post-split beneficial ownership figure of 32,810 reflects the 20-for-1 reverse split on 08/28/2025, which materially adjusted reported share counts. The spouse-held 84 shares are disclosed as indirect and explicitly disclaimed by the reporting person.

Corporate Governance Expert

TL;DR: Standard director equity grant disclosed; vesting schedule and spousal holdings are properly reported.

The statement is a routine Section 16 filing showing compliance with insider reporting for a director equity award. Key governance items are present: clear vesting terms (two equal installments over two years), disclosure of indirect spousal holdings, and an explicit disclaimer of beneficial ownership for those spouse-held shares. The signature dated 09/15/2025 provides timely attestation to the report.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Shaked Yoav

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	20,000	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 32,810 shares (Direct); Common Stock — 84 shares (Indirect, By spouse)

Footnotes (1)

1. The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period. The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Shaked Yoav

(Last) (First) (Middle)

322 W 57TH STREET, #33B

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DarioHealth Corp. [ DRIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025(1)		A		20,000	A	$0	32,810(2)	D
Common Stock								84(2)(3)	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period.

2. The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

3. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

	/s/ Yoav Shaked	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Yoav Shaked report on Form 4 for DRIO?

He reported a restricted share award of 20,000 common shares acquired on 09/11/2025, with a reported price of $0 and vesting in two equal annual installments.

How many shares does Yoav Shaked beneficially own after the reported transaction?

32,810 shares are reported as beneficially owned following the transaction, reflecting a 20-for-1 reverse stock split effected on 08/28/2025.

Are there any indirect holdings disclosed in the filing?

Yes: the filing discloses indirect ownership of 84 shares held by the reporting person’s spouse, and the reporting person disclaims beneficial ownership of those shares.

When was the Form 4 signed and filed by Yoav Shaked?

The form is signed on 09/15/2025 per the signature block included in the filing.

What are the vesting terms for the restricted shares?

The award vests in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period.